Reduction in new-onset diabetes mellitus after renal transplant with erythropoietin-stimulating agents: a retrospective cohort study

BACKGROUND: Studies have shown that erythropoietin-stimulating agents (ESAs) protect mice against the development of diabetes through direct effects on pancreatic ß cells. However, the effect of ESAs on the incidence of diabetes in humans has not been well studied. It is unknown whether exposure to...

Descripción completa

Detalles Bibliográficos
Autores principales: Montada-Atin, Tess, Choi, Diana, Woo, Minna, Retnakaran, Ravi, Huang, Michael, Prasad, G. V. Ramesh, Zaltzman, Jeffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845385/
https://www.ncbi.nlm.nih.gov/pubmed/27119016
http://dx.doi.org/10.1186/s40697-016-0114-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845385/
https://www.ncbi.nlm.nih.gov/pubmed/27119016
http://dx.doi.org/10.1186/s40697-016-0114-9

Ejemplares similares